Literature DB >> 8838670

MAP-1B/TAU functional redundancy during laminin-enhanced axonal growth.

M C DiTella1, F Feiguin, N Carri, K S Kosik, A Cáceres.   

Abstract

When cultured cerebellar macroneurons develop attached to a laminin-containing substrate or after the acute addition of laminin to the tissue culture medium, there is an acceleration in the rate and extent of axonal elongation. Furthermore, laminin is capable of inducing axonal formation and microtubule stabilization in neurons arrested at stage II of neuritic development by tau suppression (Caceres and Kosik, 1990; Caceres et al., 1991). Laminin-enhanced or induced axonal extension is paralleled by a selective and dramatic incorporation of phosphorylated MAP-1b into axonal microtubules. Axonal formation in neurons growing in the presence of laminin is prevented by treatment of the cultures with a mixture of MAP-1b and tau antisense oligonucleotides, but not by the single suppression of any one of these MAPs. However, suppression of MAP-1b, but not of tau, greatly reduces the increase in the rate and extent of axonal elongation induced by laminin. No such effects are elicited by MAP-1b antisense oligonucleotides in neurons growing in the absence of laminin, e.g. polylysine alone, where most of the MAP-1b present in the cells is dephosphorylated and not associated with the cytoskeleton. Taken collectively, these data suggest that, with regard to axonal elongation, MAP-1b and tau can be functionally substituted, and that extracellular matrix molecules, such as laminin, affect axonal extension by promoting the in vivo utilization of MAP-1b.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8838670     DOI: 10.1242/jcs.109.2.467

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  37 in total

1.  Evidence for the involvement of Tiam1 in axon formation.

Authors:  P Kunda; G Paglini; S Quiroga; K Kosik; A Caceres
Journal:  J Neurosci       Date:  2001-04-01       Impact factor: 6.167

Review 2.  Tau protein function in axonal formation.

Authors:  G Paglini; L Peris; F Mascotti; S Quiroga; A Caceres
Journal:  Neurochem Res       Date:  2000-01       Impact factor: 3.996

3.  Differential association of tau with subsets of microtubules containing posttranslationally-modified tubulin variants in neuroblastoma cells.

Authors:  L Saragoni; P Hernández; R B Maccioni
Journal:  Neurochem Res       Date:  2000-01       Impact factor: 3.996

4.  Evidence for the role of MAP1B in axon formation.

Authors:  C Gonzalez-Billault; J Avila; A Cáceres
Journal:  Mol Biol Cell       Date:  2001-07       Impact factor: 4.138

Review 5.  Neuronal polarity: demarcation, growth and commitment.

Authors:  Alfredo Cáceres; Bing Ye; Carlos G Dotti
Journal:  Curr Opin Cell Biol       Date:  2012-06-20       Impact factor: 8.382

Review 6.  Neuronal polarity.

Authors:  Sabina Tahirovic; Frank Bradke
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-09       Impact factor: 10.005

7.  Nonprimed and DYRK1A-primed GSK3 beta-phosphorylation sites on MAP1B regulate microtubule dynamics in growing axons.

Authors:  Timothy M E Scales; Shen Lin; Michaela Kraus; Robert G Goold; Phillip R Gordon-Weeks
Journal:  J Cell Sci       Date:  2009-06-23       Impact factor: 5.285

8.  Acute inactivation of tau has no effect on dynamics of microtubules in growing axons of cultured sympathetic neurons.

Authors:  I Tint; T Slaughter; I Fischer; M M Black
Journal:  J Neurosci       Date:  1998-11-01       Impact factor: 6.167

9.  Evidence for the participation of the neuron-specific CDK5 activator P35 during laminin-enhanced axonal growth.

Authors:  G Paglini; G Pigino; P Kunda; G Morfini; R Maccioni; S Quiroga; A Ferreira; A Cáceres
Journal:  J Neurosci       Date:  1998-12-01       Impact factor: 6.167

10.  Kidins220/ARMS modulates the activity of microtubule-regulating proteins and controls neuronal polarity and development.

Authors:  Alonso M Higuero; Lucía Sánchez-Ruiloba; Laura E Doglio; Francisco Portillo; José Abad-Rodríguez; Carlos G Dotti; Teresa Iglesias
Journal:  J Biol Chem       Date:  2009-11-10       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.